News | August 22, 2013

Siemens Receives 2013 Frost & Sullivan Best Practice Award for Interventional Imaging Solutions

Based on its recent analysis of the interventional radiology market, Frost & Sullivan recognized Siemens Healthcare with the "2013 North American Frost & Sullivan Award for Company of the Year." Siemens said its technology and product innovation-centered growth strategy has helped it maintain its lead and momentum in market expansion, even during the recent industry-wide slowdown. Its smart innovations, backed by the value they generate at various levels of the care continuum, including clinical care, business enterprise as well as patients, have not only enhanced the standard of care but also offered a myriad of clinical and operational benefits.

“In addition to competing effectively at both ends of the market, Siemens Healthcare can also pride itself on creating entirely new product tiers,” said Frost & Sullivan Industry Principal Nadim Daher. “Siemens has been at the forefront of the early development of hybrid interventional imaging solutions over the last 10 years, with Artis zeego being the first such solution to enter the market in 2007 — more than two years ahead of the competition.”

Siemens widened the scope of interventional imaging with its CT-like rotational angiography three-dimensional (3-D) visualization at the bed side in the in the interventional lab with its syngo DynaCT. Nearly 10 years later, Siemens' DynaCT is still the leader in rotational angiography. Its latest product launches have enhanced all the major product elements of image quality, acquisition speed, and the dose and contrast efficiency in 3-D imaging.

Siemens Healthcare’s new line of premium angiography systems, the Artis Q product line, embodies enhancements such as syngo DynaCT Micro as well as numerous other advances such as Q.zen. In the Q.zen configuration, advances include a newly designed digital crystalline silicon detector that allows better detail visualization at lower radiation dosages. These new systems incorporate Siemens’ second-generation of proprietary X-ray tube flat emitter technology, which also contributes to higher dose efficiency of these systems.

Siemens can be deemed the first vendor to ever bring functional imaging to a clinical setting during interventional procedures. Similar to its hybrid interventional imaging solution, Siemens’ parenchymal blood volume (PBV) technology, syngo DynaPBV, is another industry first. Following its release in 2009 as a breakthrough neurology application for brain imaging (syngo DynaPBV Neuro), the syngo DynaPBV Body applies 3-D functional imaging in a whole new set of interventional radiology procedures.

The highly sophisticated algorithms that constitute the CARE and CLEAR software packages represent another layer of product differentiation for Siemens. The CARE portfolio offers cutting-edge dose reduction, monitoring and reporting techniques, and is delivered to customers as standard — not at added costs — in all of Siemens’ Artis zee, zeego, Q and Q.zen systems.

“As an established interventional radiology vendor of choice in the largest number of university and academic hospitals in the U.S., Siemens Healthcare is best suited to address the needs of newly consolidated hospital networks,” noted Daher. “It is also strategically placed to help in the creation of clinical specialty centers of excellence in cardiology, trauma and oncology.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in terms of growth strategy and implementation. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.

More information: www.usa.siemens.com/interventional-imaging

 

 

Related Content

Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Merit Medical Announces Advanced Interventional Cardiology Transradial Intervention Education Course
News | Radial Access| August 23, 2017
Merit Medical Systems Inc. will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij,...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Virtual Phantoms Inc. Releases VirtualDose-IR
Technology | Radiation Dose Management| August 07, 2017
Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional...
Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D
News | Interventional Radiology| August 03, 2017
Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
Overlay Init